Mobidiag Announces Completion of €10m Equity Investment from Autobio Diagnostics

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today announces the completion of the €10m equity investment from Autobio Diagnostics (‘Autobio’), as announced on 18 December 2018, with receipt of all funds.

Article: BusinessWire